Expert: technological companies lay the foundation for modern industry
Projects that are being worked on by science and high-technology companies based in Latvia lay the foundation for modern industry focused on the future, said the founder and manager of Commercialization Reactor acceleration platform Nikolajs Adamovics after the investors and partners day event.
He says that projects that were presented during the event are at different stages of development – some are looking for investments or industry guru support, others are looking for ways to commence production, additional research or protection of intellectual property. At the same time, there are companies that are preparing for the next big leap, as BNN was informed by the organization.
«For example, Nanooptometrics is busy developing technologies that allow the use of high precision properties of light for measurements on a nano level. Measurement devices of such calibre can help create very flat surfaces for use in industries that require high-precision (computer hard disks, semiconductors, solar battery units) production,» the expert comments. Adamovics notes that precise measurements and smart control of production processes is the direction in which multiple companies are already working, forming a solid foundation for potential development of this industry.
The biggest projects presented at the investors and partners day develop ideas in different science fields: from modern biochemical solutions, robotised production equipment to AI products, smart materials and technologies for space exploration. Technologies developed by OLED manufacturer Evolved could potentially affect not only production of large displays, but also bio-markers, sensors and lasers. «I should add that Lomonosov Moscow State University uses knowledge of specialists from Latvia’s Institute of Solid State Physics to realize some of their ideas,» the expert continues.
Vita Sture, representative of Semantic Intelligence, reveals the importance of quick and cheap error corrections.
«The production process of new types of medicine can last for decades and cost billions of euros. Because of that, it is highly important to determine if there is any point in working with specific components at the very beginning of the production process. What I mean is uncovering possible errors quickly and making sure those mistakes do not cost a lot of money. We offer an AI system that helps speed up research in early stages of development,» says the company’s representative.